Head-to-Head Startup Ranking & Discovery
AAnto Biosciences logo

Anto Biosciences

AI · US · Early-stage
anto.bio
Artificial IntelligenceGenerative AIBiotechGenomicsDrug discovery

Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures. Founded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed sparsification) and David (Harvard Medical School Gastroenterology, J&J), second-time founders who published the breakthrough at leading machine learning AI conferences and Nature.

Founded
2025
Headquarters
San Francisco, CA, USA
Team size
1–10
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1488 Elo
1487
💰 Conviction
Provisional
1492
🔥 Momentum
Provisional
1484
🧲 Talent
Provisional
Total matchups0
⚔️ Vote on today's matchups →

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →